1. Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis. Issue 1 (December 2016) Authors: Gomez, G.; Dowdy, D.; Bastos, M.; Zwerling, A.; Sweeney, S.; Foster, N.; Trajman, A.; Islam, M.; Kapiga, S.; Sinanovic, E.; Knight, G.; White, R.; Wells, W.; Cobelens, F.; Vassall, A. Journal: BMC infectious diseases Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The implementation of rifapentine and isoniazid (3HP) in two remote Arctic communities with a predominantly Inuit population, the Taima TB 3HP study. Issue 1 (1st January 2020) Authors: Alvarez, G. G.; Van Dyk, D.; Mallick, R.; Lesperance, S.; Demaio, P.; Finn, S.; Potvin, S. Edmunds; Patterson, M.; Pease, C.; Amaratunga, K.; Hui, C.; Cameron, D.W.; Mulpuru, S.; Aaron, S.D.; Momoli, F.; Zwerling, A. Journal: International journal of circumpolar health Issue: Volume 79:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗